Inhibrx shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Inhibrx
Tip: Access up to 7 years of quarterly data
All positions including Inhibrx held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibrx by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $691k | 18k | 38.00 |
| 2023-09-30 | $334k | 18k | 18.35 |
| 2023-06-30 | $472k | 18k | 25.96 |
| 2023-03-31 | $335k | 18k | 18.87 |
| 2022-12-31 | $437k | 18k | 24.64 |
| 2022-09-30 | $309k | 17k | 17.95 |
| 2022-06-30 | $196k | 17k | 11.38 |
| 2022-03-31 | $384k | 17k | 22.29 |
| 2021-12-31 | $503k | 12k | 43.65 |
| 2021-09-30 | $384k | 12k | 33.31 |
| 2021-06-30 | $317k | 12k | 27.51 |
| 2020-12-31 | $131k | 4.0k | 33.06 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors